Burning Rock Biotech's market cap is currently $96.17M. The company's EPS TTM is $-0.125; its P/E ratio is ―; Burning Rock Biotech is scheduled to report earnings on September 8, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
